Aeglea BioTherapeutics
spy phase clinical trial design | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2023
Slide
13 of 37
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
October 2023
spy phase clinical trial design | Aeglea BioTherapeutics
Related slides by other companies
23andMe
Investor Presentation
January 2024
next steps | 23andMe
argenx SE
Results
May 2023
musk agonist with broad potential in neuromuscular disease | argenx SE
Kymera
Investor Presentation
August 2023
objectives a a | Kymera
MaxCyte
Investor Presentation
January 2024
enabled active clinical trials | MaxCyte
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights